| abstract |
Compounds of formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections. In said formula, (A) is (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l), (m), (n), (o) or (p); (I) wherein R<1> is H or C1-4alkyl; R<2> is H, C1-4alkyl or C3-6cycloalkyl; R<3> is (q), (r), (s), (t), (u), (v) or (w); R<4> is H or C1-4alkyl; (x) indicates that one of the two designated bonds is a double bond and the other is a single bond; R<5> is CH2 when the bond to which it is attached is a double bond; or R<5> is H or C1-4alkyl when the bond to which it is attached is a single bond; R<6> is H or C1-4alkyl; R<7> is H, C1-6alkyl or -C0-6alkyl-Ar; Y is H, C1-4alkyl, N(R')2, NHC(O)R', NHCH2C(O)R' or NHC(O)CH=CHR'; each X independently is H, C1-4alkyl, CH2OH, OR', SR', CN, N(R')2, CH2N(R')2, NO2, CF3, CO2R', CON(R')2, COR', NR'C(O)R', F, Cl, Br, I or -S(O)rCF3; W is S or O, Q is H or C1-4alkyl; M is CH2 or O; L is CH2 or C(O); E is O or NR'; each R' independently is H, C1-6alkyl or -C0-6alkyl-Ar; and r is 0, 1 or 2; or a pharmaceutically acceptable salt thereof. |